Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Kamuvudine-9 by Inflammasome Therapeutics for Graves' Ophthalmopathy: Likelihood of Approval
Kamuvudine-9 is under clinical development by Inflammasome Therapeutics and currently in Phase I for Graves' Ophthalmopathy. According to GlobalData, Phase...
Data Insights
SOM-401 by Inflammasome Therapeutics for Geographic Atrophy: Likelihood of Approval
SOM-401 is under clinical development by Inflammasome Therapeutics and currently in Phase I for Geographic Atrophy. According to GlobalData, Phase...